4.7 Article

Cornea organoids from human induced pluripotent stem cells

Journal

Scientific Reports
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep41286

Keywords

-

Funding

  1. NIH [5T32EY007143, R01EY009769, 5P30EY001765, K99/R00 EY024648, EY015128, NIH EY02576, EY014800]
  2. Maryland Stem Cell Research Foundation
  3. Foundation Fighting Blindness, Research to Prevent Blindness,
  4. Knights Templar Eye Foundation (KTEF) Career-Starter Research Grant
  5. Edward N. and Della L. Thome Memorial Foundation grant for AMD Research
  6. BrightFocus Foundation
  7. Guerrieri Family Foundation
  8. Mr. and Mrs. Robert and Clarice Smith
  9. [EY026104]

Ask authors/readers for more resources

The cornea is the transparent outermost surface of the eye, consisting of a stratified epithelium, a collagenous stroma and an innermost single-cell layered endothelium and providing 2/3 of the refractive power of the eye. Multiple diseases of the cornea arise from genetic defects where the ultimate phenotype can be influenced by cross talk between the cell types and the extracellular matrix. Cell culture modeling of diseases can benefit from cornea organoids that include multiple corneal cell types and extracellular matrices. Here we present human iPS cell-derived organoids through sequential rounds of differentiation programs. These organoids share features of the developing cornea, harboring three distinct cell types with expression of key epithelial, stromal and endothelial cell markers. Cornea organoid cultures provide a powerful 3D model system for investigating corneal developmental processes and their disruptions in diseased conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available